<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; Sunshine</title>
	<atom:link href="http://www.tapanray.in/tag/sunshine/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Declining MR Access to Doctors Prompts Increased Digital Engagement</title>
		<link>http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=declining-mr-access-to-doctors-prompts-increased-digital-engagement</link>
		<comments>http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/#comments</comments>
		<pubDate>Sun, 02 Oct 2016 23:58:07 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Aceess]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[channels]]></category>
		<category><![CDATA[Declining]]></category>
		<category><![CDATA[Department]]></category>
		<category><![CDATA[digital]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[joint]]></category>
		<category><![CDATA[mandatory]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[of pharmaceuticals]]></category>
		<category><![CDATA[Pant]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pfizerline]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[platforms]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Representatives]]></category>
		<category><![CDATA[sales]]></category>
		<category><![CDATA[secretary]]></category>
		<category><![CDATA[Sudhanshu]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[Tapan Ray]]></category>
		<category><![CDATA[UCPMP]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=7850</guid>
		<description><![CDATA[The trigger point for a disruptive change in the pharma marketing playbook now seems to be not just on the horizon, but could soon move to a countdown stage, in India. On Friday, September 16, 2016, at a seminar on &#8230; <a href="http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/declining-mr-access-to-doctors-prompts-increased-digital-engagement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>India’s Pharma Marketing Code (UCPMP): Is It Crafted Well Enough To Deliver The Deliverables?</title>
		<link>http://www.tapanray.in/indias-pharma-marketing-code-ucpmp-is-it-crafted-well-enough-to-deliver-the-deliverables/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=indias-pharma-marketing-code-ucpmp-is-it-crafted-well-enough-to-deliver-the-deliverables</link>
		<comments>http://www.tapanray.in/indias-pharma-marketing-code-ucpmp-is-it-crafted-well-enough-to-deliver-the-deliverables/#comments</comments>
		<pubDate>Mon, 29 Dec 2014 00:00:40 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[deliverables]]></category>
		<category><![CDATA[delivery]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[UCPMP]]></category>
		<category><![CDATA[Uniform]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=6279</guid>
		<description><![CDATA[On December 12, 2014, the Department of Pharmaceuticals (DoP) of the Government of India announced details of the ‘Uniform Code of Pharmaceutical Marketing Practices (UCPMP)’, which would be effective across the country from January 1, 2015. Just to recapitulate, the &#8230; <a href="http://www.tapanray.in/indias-pharma-marketing-code-ucpmp-is-it-crafted-well-enough-to-deliver-the-deliverables/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/indias-pharma-marketing-code-ucpmp-is-it-crafted-well-enough-to-deliver-the-deliverables/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To Curb Pharma Marketing Malpractices in India Who Bells the Cat?</title>
		<link>http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat</link>
		<comments>http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/#comments</comments>
		<pubDate>Mon, 18 Mar 2013 00:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[bribe]]></category>
		<category><![CDATA[cat]]></category>
		<category><![CDATA[commission]]></category>
		<category><![CDATA[Committee]]></category>
		<category><![CDATA[curb]]></category>
		<category><![CDATA[curbing]]></category>
		<category><![CDATA[disclosure]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[E&Y]]></category>
		<category><![CDATA[financial]]></category>
		<category><![CDATA[Game]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[HHS]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[indictment]]></category>
		<category><![CDATA[inertia]]></category>
		<category><![CDATA[interest]]></category>
		<category><![CDATA[intriguing]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Jyoti]]></category>
		<category><![CDATA[Law]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[Mirdha]]></category>
		<category><![CDATA[MoH]]></category>
		<category><![CDATA[mouse]]></category>
		<category><![CDATA[Netherlands]]></category>
		<category><![CDATA[Obama]]></category>
		<category><![CDATA[Parliament]]></category>
		<category><![CDATA[Parliamentary]]></category>
		<category><![CDATA[Patient]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[Planning]]></category>
		<category><![CDATA[Protection]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Reform]]></category>
		<category><![CDATA[slovakia]]></category>
		<category><![CDATA[Standing]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[transparency]]></category>
		<category><![CDATA[UCPMP]]></category>
		<category><![CDATA[UK]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://www.tapanray.in/?p=2050</guid>
		<description><![CDATA[Bribing doctors by the pharmaceutical companies directly or indirectly, as reported frequently by the media all over the world, including India, to prescribe their respective brand of drugs has now reached an alarming proportion, jeopardizing patients’ interest, seriously more than &#8230; <a href="http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-curb-pharma-marketing-malpractices-in-india-who-bells-the-cat/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does India need an equivalent of ‘The Physician Payment Sunshine Act’ of the US for transparency in pharmaceutical marketing?</title>
		<link>http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing</link>
		<comments>http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/#comments</comments>
		<pubDate>Mon, 14 Nov 2011 00:00:41 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[Compliance]]></category>
		<category><![CDATA[equivalent]]></category>
		<category><![CDATA[Ethics]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[transparency]]></category>
		<category><![CDATA[UCPMP]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=175</guid>
		<description><![CDATA[Currently a strong and palpable public sentiment against corruption has engulfed India albeit more than what we witness in movements like &#8216;Occupy Wall Street&#8217; against systemic corruption not only in the US but in a large number of cities across &#8230; <a href="http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/does-india-need-an-equivalent-of-the-physician-payment-sunshine-act-of-the-us-for-transparency-in-pharmaceutical-marketing/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>To restore patients’ confidence MCI has amended its regulations… to strengthen it further will the government consider an Indian version of ‘Physician Payment Sunshine Act’?</title>
		<link>http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act</link>
		<comments>http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/#comments</comments>
		<pubDate>Mon, 08 Feb 2010 01:30:08 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[amended]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[confidence]]></category>
		<category><![CDATA[consider]]></category>
		<category><![CDATA[Council]]></category>
		<category><![CDATA[doctors]]></category>
		<category><![CDATA[DoP]]></category>
		<category><![CDATA[further]]></category>
		<category><![CDATA[Government]]></category>
		<category><![CDATA[has]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[its]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[MCI]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Patients]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[restore]]></category>
		<category><![CDATA[strengthen]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[version]]></category>
		<category><![CDATA[Will]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=470</guid>
		<description><![CDATA[In today’s India, blatant commercialization of the noble healthcare services has reached its nadir, as it were, sacrificing the ethics and etiquettes both in medical and pharmaceutical marketing practices at the altar of unlimited greed. As a result of fast &#8230; <a href="http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/to-restore-patients-confidence-mci-has-amended-its-regulations-to-strengthen-it-further-will-the-government-consider-an-indian-version-of-physician-payment-sunshine-act/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>For greater transparency in the relationship between physicians and the pharmaceutical companies, does India need an Act like, proposed ‘The Physician Payment Sunshine Act’ of the USA?</title>
		<link>http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa</link>
		<comments>http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 01:30:12 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Act]]></category>
		<category><![CDATA[an]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[between]]></category>
		<category><![CDATA[Code]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Does]]></category>
		<category><![CDATA[greater]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[like]]></category>
		<category><![CDATA[Malpractices]]></category>
		<category><![CDATA[marketing]]></category>
		<category><![CDATA[need]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Payment]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Physician]]></category>
		<category><![CDATA[physicians]]></category>
		<category><![CDATA[proposed]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[relationship]]></category>
		<category><![CDATA[Sunshine]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[transparency]]></category>
		<category><![CDATA[USA]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=724</guid>
		<description><![CDATA[As we discussed earlier, to make the pharmaceutical companies disclose and report various types of payments made to the physicians, two Senators of the United States of America, Chuck Grassley and Herb Kohl introduced a bill called ‘The Physician Payment &#8230; <a href="http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/for-greater-transparency-in-the-relationship-between-physicians-and-the-pharmaceutical-companies-does-india-need-an-act-like-proposed-the-physician-payment-sunshine-act-of-the-usa/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
